The case for a stratified application of targeted agents against pancreatic cancer

EBioMedicine. 2021 May:67:103344. doi: 10.1016/j.ebiom.2021.103344. Epub 2021 Apr 25.
No abstract available

MeSH terms

  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use*
  • Carcinoma, Pancreatic Ductal / drug therapy*
  • Carcinoma, Pancreatic Ductal / metabolism
  • Clinical Trials as Topic
  • Gene Regulatory Networks / drug effects
  • Humans
  • Molecular Targeted Therapy
  • Pancreatic Neoplasms / drug therapy*
  • Pancreatic Neoplasms / metabolism
  • Treatment Outcome

Substances

  • Antineoplastic Agents